Indegene Strengthens European Presence with New Centre in London
Indegene Limited, established in 1998, is a digital-first healthcare and technology company that supports biopharmaceutical, emerging biotech, and medical device companies in product development and market entry.
Indegene Limited, a digital-first life sciences commercialization company, has announced the opening of a new centre in London as part of its strategic expansion in Europe. This move underscores Indegene's commitment to enabling life sciences clients in the region to be future-ready with an AI-first approach. The new centre will serve as a strategic hub for consulting and commercialization solutions, providing clients with enhanced capabilities in modernizing their operations. Indegene's workforce in Europe is being strengthened with expertise in consulting, creative, data and analytics, engineering, and customer experience.
The company's expansion in Europe is further supported by its existing centres in Germany, Ireland, and Switzerland, along with its recent acquisition of Trilogy Writing & Consulting GmbH, a global provider of special medical writing capabilities. Indegene's presence in Europe is significant, with the world's top 20 global biopharma companies relying on its services for their commercialization needs. Indegene Limited has a market capitalization of over Rs 12,000 crore and a PE ratio of 33.
DSIJ's DSIJ's ‘Mid Bridge’ service recommends well researched Mid-Cap stocks for smart investing. If this interests you, do download the service details here.
Indegene Limited, established in 1998, is a digital-first healthcare and technology company that supports biopharmaceutical, emerging biotech, and medical device companies in product development and market entry. The company offers a wide range of solutions, including drug development, clinical trials, regulatory submissions, and sales and marketing operations. Indegene's business model is centred around enterprise commercial solutions, omnichannel activation, and enterprise medical solutions, providing clients with comprehensive digital marketing and regulatory services. The company has a strong geographical presence, with significant revenue contributions from North America and Europe. Indegene's strategic collaborations and innovative digital platforms further enhance its market positioning, making it a key player in the life sciences sector.
Disclaimer: The article is for informational purposes only and not investment advice.